|
Volumn 33, Issue 2, 2001, Pages 424-432
|
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B
a b c d e f g h i j k k k k |
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA POLYMERASE;
HEPATITIS B ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
MUTANT PROTEIN;
VIRUS DNA;
VIRUS ENZYME;
ADULT;
AGED;
ARTICLE;
CANADA;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HUMAN;
INFECTION PREVENTION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
POSTOPERATIVE CARE;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SURVIVAL;
UNITED STATES;
|
EID: 2942559300
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1053/jhep.2001.21554 Document Type: Article |
Times cited : (420)
|
References (35)
|